Stockscreener 앱 받기
73.78
0.12%
0.09
전일 마감가:
$73.69
열려 있는:
$73.38
하루 거래량:
5.07M
Relative Volume:
0.71
시가총액:
$93.58B
수익:
$386.46B
순이익/손실:
$4.49B
주가수익비율:
20.61
EPS:
3.58
순현금흐름:
$4.78B
1주 성능:
+0.86%
1개월 성능:
+16.34%
6개월 성능:
+11.87%
1년 성능:
+27.05%
1일 변동 폭
$73.06
$74.49
1주일 범위
$72.86
$74.53
52주 변동 폭
$43.56
$74.53
CVS헬스 Stock (CVS) Company Profile
명칭
Cvs Health Corp
전화
(401) 765-1500
주소
ONE CVS DR., WOONSOCKET
CVS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
73.78 | 93.46B | 386.46B | 4.49B | 4.78B | 3.58 |
|
UNH
Unitedhealth Group Inc
|
315.39 | 281.10B | 422.82B | 22.09B | 25.27B | 23.08 |
|
CI
Cigna Group
|
305.31 | 81.15B | 261.22B | 5.40B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
313.64 | 69.37B | 189.25B | 5.35B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
307.92 | 37.52B | 123.11B | 1.58B | 2.44B | 13.03 |
CVS헬스 Stock (CVS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-18 | 업그레이드 | UBS | Neutral → Buy |
| 2025-08-14 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | 업그레이드 | Edward Jones | Hold → Buy |
| 2024-12-03 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-11-18 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-10-04 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-05-30 | 개시 | Robert W. Baird | Neutral |
| 2024-05-07 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-05-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-05-01 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | 개시 | Barclays | Equal Weight |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2023-12-22 | 개시 | HSBC Securities | Buy |
| 2023-09-19 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-09-12 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | 다운그레이드 | Edward Jones | Buy → Hold |
| 2023-05-26 | 개시 | Piper Sandler | Overweight |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 재개 | Morgan Stanley | Overweight |
| 2022-06-17 | 개시 | Loop Capital | Buy |
| 2022-05-27 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-02-11 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | 개시 | Goldman | Buy |
| 2021-12-01 | 개시 | Seaport Research Partners | Buy |
| 2021-05-19 | 개시 | Wells Fargo | Equal Weight |
| 2021-03-17 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-01-08 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-09-17 | 개시 | Piper Sandler | Overweight |
| 2020-07-01 | 개시 | SVB Leerink | Mkt Perform |
| 2020-05-14 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | 재개 | RBC Capital Mkts | Outperform |
| 2019-09-12 | 개시 | Deutsche Bank | Buy |
| 2019-06-05 | 업그레이드 | Standpoint Research | Hold → Buy |
| 2019-04-29 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | 개시 | Guggenheim | Buy |
| 2019-04-15 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2019-04-10 | 재확인 | BofA/Merrill | Buy |
| 2019-03-13 | 개시 | Bernstein | Outperform |
| 2019-02-20 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | 개시 | UBS | Buy |
| 2018-12-18 | 개시 | Barclays | Overweight |
| 2018-11-29 | 재개 | Goldman | Neutral |
| 2018-11-28 | 개시 | Evercore ISI | Outperform |
| 2018-10-26 | 재개 | Wolfe Research | Peer Perform |
| 2018-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-02-27 | 재개 | BofA/Merrill | Buy |
| 2018-02-13 | 재확인 | Citigroup | Neutral |
모두보기
CVS헬스 주식(CVS)의 최신 뉴스
Is CVS Health Stock Outperforming the Dow? - MSN
Amundi Sells 2,295,578 Shares of CVS Health Corporation $CVS - MarketBeat
Does CVS Health Corporation outperform in volatile marketsForecast Cut & AI Powered Buy and Sell Recommendations - خودرو بانک
8 Knots Management LLC Increases Stock Position in CVS Health Corporation $CVS - MarketBeat
New York governor issues order to bypass Trump administration's COVID vaccine limits - Reuters
CVS, Walgreens To Buy Pharmacy Assets From Rite Aid Corp: Retail Sentiment Brightens - MSN
CVS (CVS) Faces Lawsuit After Dropping Eli Lilly's Drug from Cov - GuruFocus
CVS Caremark facing class action suit for dropping coverage of Lilly's Zepbound - Seeking Alpha
CVS Health (CVS): Bernstein Maintains Rating, Raises Price Targe - GuruFocus
Bernstein Raises CVS Health's PT to $77 from $72, Maintains Market Perform - AInvest
State of Wyoming Makes New $291,000 Investment in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Purchased by AQR Capital Management LLC - MarketBeat
BW Gestao de Investimentos Ltda. Lowers Stock Holdings in CVS Health Corporation $CVS - MarketBeat
AlTi Global Inc. Sells 46,592 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Acquired by Canada Pension Plan Investment Board - MarketBeat
Panagora Asset Management Inc. Raises Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Baird Financial Group Inc. Increases Stake in CVS Health Corporation $CVS - MarketBeat
OMERS ADMINISTRATION Corp Sells 7,705 Shares of CVS Health Corporation $CVS - MarketBeat
How high can CVS Health Corporation stock goWeekly Market Outlook & Fast Exit and Entry Trade Guides - Newser
CVS Caremark’s Boosting of Wegovy Over Zepbound Fuels Lawsuits - Bloomberg Law News
Key metrics from CVS Health Corporation’s quarterly dataWeekly Trend Recap & Long-Term Safe Investment Plans - Newser
CVS Health Corporation $CVS Shares Sold by Chiron Capital Management LLC - MarketBeat
Is CVS Health Stock Outperforming The Dow? - Barchart.com
Risk adjusted return profile for CVS Health Corporation analyzedEarnings Overview Summary & Low Volatility Stock Suggestions - Newser
Caisse DE Depot ET Placement DU Quebec Reduces Stake in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation (NYSE:CVS) Given Average Rating of "Buy" by Brokerages - MarketBeat
CVS Caremark Faces Lawsuit for Favoring Wegovy Over Zepbound (1) - Bloomberg Law News
10 Top-Performing Dividend Stocks - Morningstar
Lansforsakringar Fondforvaltning AB publ Sells 11,537 Shares of CVS Health Corporation $CVS - MarketBeat
Can CVS Health Corporation rally from current levelsPortfolio Risk Summary & Technical Pattern Alert System - Newser
63% of Americans Plan Flu Shots: CVS Health Expands with 3-in-1 Testing in 38 States for 2025-2026 - Stock Titan
Te Ahumairangi Investment Management Ltd Trims Position in CVS Health Corporation $CVS - MarketBeat
Volatility clustering patterns for CVS Health Corporation2025 Risk Factors & Weekly Setup with ROI Potential - Newser
Is CVS Health Corporation forming a double bottomJuly 2025 Breakouts & Growth Focused Stock Reports - خودرو بانک
CVS Health Corporation $CVS Shares Sold by Rafferty Asset Management LLC - MarketBeat
Ieq Capital LLC Purchases 180,495 Shares of CVS Health Corporation $CVS - MarketBeat
Cvs Health stock hits 52-week high at 73.26 USD - Investing.com
Former CVS CFO Guertin joins board of Aledade, largest US primary care networkProvidence Business First - The Business Journals
Price momentum metrics for CVS Health Corporation explained2025 Dividend Review & Growth-Oriented Investment Plans - Newser
CVS, Walgreens Limit COVID Vaccines in Some States as Rules Shift - The Herald Palladium
CVS Health Sees Momentum in HCB Segment Amid Utilization Pressure - sharewise.com
CVS Health Sees Momentum In HCB Segment Amid Utilization Pressure - Barchart.com
Cvs Health stock hits 52-week high at 73.26 USD By Investing.com - Investing.com Australia
CVS헬스 (CVS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
1.31%
자본화:
|
볼륨(24시간):